Activation of monocytic cells by immunostimulatory lipids conjugated to peptide antigens(404 views) Galdiero S, Vitiello M, Finamore E, Mansi R, Galdiero M, Morelli G, Tesauro D
Department of Biological Sciences, University of Naples Federico II, Istituto di Biostrutture e Bioimmagini CNR, Via Mezzocannone 16, 80134 Naples, Italy
Department of Experimental Medicine, Section of Microbiology and Clinical Microbiology, Second University of Naples, 80138, Naples, Italy
References: Arnon, R., Synthetic peptides as the basis for vaccine design (1991) Mol. Immunol., 28, pp. 209-21
Benmohamed, L., Wechsler, S.L., Nesburn, A.B., Lipopeptide vaccines-yesterday, today, and tomorrow (2002) Lancet Infect. Dis., 2, pp. 425-431
Berzofsky, J.A., Ahlers, J.D., Belyakov, I.M., Strategies for designing and optimizing new generation vaccines (2002) Nat. Rev. Immunol., 3, pp. 209-219
Singh, M., O'Hagan, D.T., Recent advances in vaccine adjuvants (2002) Pharmaceutical Research, 19 (6), pp. 715-728. , DOI 10.1023/A:1016104910582
Elliott, S.L., Pye, S., Le, T., Mateo, L., Cox, J., MacDonald, L., Scalzo, A.A., Suhrbier, A., Peptide based cytotoxic T-cell vaccines
delivery of multiple epitopes, help, memory and problems (1999) Vaccine, 17 (15-16), pp. 2009-2019. , DOI 10.1016/S0264-410X(98)00468-X, PII S0264410X9800468X
Gupta, R.K., Siber, G.R., Adjuvants for human vaccines-current status, problems and future prospects (1995) Vaccine, 13, pp. 1263-1276
Toth, I., Danton, M., Flinnand, N., Gibbons, W.A., A combined adjuvant and carrier system for enhancing synthetic peptides immunogenicity utilising lipidic amino acids (1993) Tetrahedron Lett., 34, pp. 3925-3928
Moyle, P.M., Toth, I., Self-adjuvanting lipopeptide vaccines (2008) Curr. Med. Chem., 15, p. 506
Olive, C., Tothand, I., Jackson, D.J., Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies (2001) Mini-Rev. Med. Chem., 1, pp. 429-438
Olive, C., Batzloff, M., Horvath, A., Clair, T., Yarwood, P., Toth, I., Good, M.F., Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct (2004) Indian Journal of Medical Research, Supplement, 119 (MAY), pp. 88-94
Deres, K., Schild, H., Wiesmuller, K.-H., Jung, G., Rammensee, H.-G., In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine (1989) Nature, 342 (6249), pp. 561-564. , DOI 10.1038/342561a0
Mora, A., Tam, J., Controlled lipidation and encapsulation of peptides as a useful approach to mucosal immunizations (1998) J. Immunol., 161, pp. 3616-3623
Nardelli, B., Haser, P.B., Tam, J.P., Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses (1994) Vaccine, 12 (14), pp. 1335-1339. , DOI 10.1016/S0264-410X(94)80062-5
Zeng, W., Jackson, D.C., Murray, J., Rose, K., Brown, L.E., Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens (2000) Vaccine, 18, pp. 1031-1039
BenMohamed, L., Gras-Masse, H., Tartar, A., Daubersies, P., Brahimi, K., Bossus, M., Thomas, A., Druilhe, P., Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees (1997) European Journal of Immunology, 27 (5), pp. 1242-1253
Zhong, G., Toth, I., Reid, R., Brunham, R.C., Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis (1993) Journal of Immunology, 151 (7), pp. 3728-3736
Toth, I., Flinn, N., Gibbons, W.A., Good, M., Hayman, W., Brown, F., (1996) Immunological Evaluation of the Lipid-core-peptide (LCP) Adjuvant/carrier System, pp. 810-811. , Peptides Chemistry, Structure and Biology, ed. T. Pravin, R. Kaumaya and S. Hodges, Mayflower Scientific Ltd., Kingswinford
Olive, C., Hsien, K., Horváth, A., Clair, T., Yarwood, P., Toth, I., Good, M.F., Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides (2005) Vaccine, 23, pp. 298-2303
Olive, C., Ho, M.-F., Dyer, J., Lincoln, D., Barozzi, N., Toth, I., Good, M.F., Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus (2006) Journal of Infectious Diseases, 193 (12), pp. 1666-1676. , DOI 10.1086/504266
Hayman, W.A., Toth, I., Flinn, N., Scanlon, M., Good, M.F., Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to A helical group a streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology (2002) Immunology and Cell Biology, 80 (2), pp. 178-187. , DOI 10.1046/j.1440-1711.2002.01067.x
De Oliveira, E., Villen, J., Giralt, E., Andreu, D., Synthetic approaches to multivalent lipopeptide dendrimers containing cyclic disulfide epitopes of foot-and-mouth disease virus (2003) Bioconjugate Chemistry, 14 (1), pp. 144-152. , DOI 10.1021/bc025577f
Tam, J.P., Lu, Y.-A., Vaccine engineering: Enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes (1989) Proceedings of the National Academy of Sciences of the United States of America, 86 (23), pp. 9084-9088. , DOI 10.1073/pnas.86.23.9084
Haro, I., Perez, S., Garcia, M., Chan, W.C., Ercilla, G., Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: A robust method for vaccine design (2003) FEBS Letters, 540 (1-3), pp. 133-140. , DOI 10.1016/S0014-5793(03)00249-7
Fitzmaurice, C.J., Brown, L.E., McInerney, T.L., Jackson, D.C., The assembly and immunological properties of non-linear synthetic immunogens containing T-cell and B-cell determinants (1996) Vaccine, 14 (6), pp. 553-560. , DOI 10.1016/0264-410X(95)00217-O
Depil, S., Morales, O., Castelli, F.A., Delhem, N., Francois, V., Georges, B., Dufosse, F., Pancre, V., Determination of a HLA II promiscuous peptide cocktail as potential vaccine against EBV latency II malignancies (2007) Journal of Immunotherapy, 30 (2), pp. 215-226. , DOI 10.1097/01.cji.0000211338.99137.4f, PII 0000237120070200000008
Shen, L., Schroers, R., Hammer, J., Huang, X.F., Chen, S.-Y., Identification of a MHC class-II restricted epitope in carcinoembryonic antigen (2004) Cancer Immunology, Immunotherapy, 53 (5), pp. 391-403. , DOI 10.1007/s00262-003-0455-y
Hammer, J., Sturniolo, T., Sinigaglia, F., HLA class II peptide binding specificity and autoimmunity (1997) Adv. Immunol., 66, pp. 67-100
Kwok, W.W., Gebe, J.A., Liu, A., Agar, S., Ptacek, N., Hammer, J., Koelle, D.M., Nepom, G.T., Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research (2001) Trends Immunol., 22, pp. 583-588
BenMohamed, L., Bertrand, G., McNamara, C.D., Gras-Masse, H., Hammer, J., Wechsler, S.L., Nesburn, A.B., Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity (2003) Journal of Virology, 77 (17), pp. 9463-9473. , DOI 10.1128/JVI.77.17.9463-9473.2003
Rost, B., Sander, C., Prediction of protein secondary structure at better than 70% accuracy (1993) J. Mol. Biol., 232, pp. 584-589
Prevelige, P., Fasman, G.D., (1990) Prediction of Protein Structure and Principles of Protein Conformation, , Plenum Press, New York
Smith, S., Robinson, N.J., Age-Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global Review (2002) J. Infect. Dis., 186 (SUPPL. 1), pp. 3-28
Bernstein, D.I., Stanberry, L.R., Herpes simplex virus vaccines (1999) Vaccine, 17 (13-14), pp. 1681-1689. , DOI 10.1016/S0264-410X(98)00434-4, PII S0264410X98004344
Aymard, M., Current epidemiology of herpes (2002) Pathol. Biol., 50, pp. 425-435
Cush, S.S., Anderson, K.M., Ravneberg, D.H., Weslow-Schmidt, J.L., Flano, E., Memory generation and maintenance of CD8+ T cell function during viral persistence (2007) Journal of Immunology, 179 (1), pp. 141-153
Chentoufi, A.A., Zhang, X., Lamberth, K., Dasgupta, G., Bettahi, I., Nguyen, A., Wu, M., Benmohamed, L., HLA-A *0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D (2008) J. Immunol., 180, pp. 426-437
Chou, P.Y., Fasman, G.D., Prediction of protein conformation (1974) Biochemistry, 13, pp. 222-245
Galdiero, M., Tortora, A., Damiano, N., Vitiello, M., Longanella, A., Galdiero, E., Induction of cytokine mRNA expression in U937 cells by Salmonella typhimurium porins is regulated by different phosphorylation pathways (2005) Medical Microbiology and Immunology, 194 (1-2), pp. 13-23. , DOI 10.1007/s00430-003-0209-7
Taylor, M.F., Paulauskis, J.D., Weller, D.D., Kobzik, L., In vitro efficacy of morpholino-modified antisense oligomers directed against tumor necrosis factor-α mRNA (1996) Journal of Biological Chemistry, 271 (29), pp. 17445-17452. , DOI 10.1074/jbc.271.29.17445
Cuenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher, T.F., Yang, P.R., Lee, J.C., SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1 (1995) FEBS Lett., 364, pp. 229-233
Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T., Saltiel, A.R., PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo (1995) J. Biol. Chem., 270, pp. 27489-27494
Bonny, C., Oberson, A., Negri, S., Sauser, C., Schorderet, D.F., Cell-permeable peptide inhibitors of JNK. Novel blockers of β-cell death (2001) Diabetes, 50 (1), pp. 77-82
Yin, E.T., Galanos, C., Kinsky, S., Bradshaw, R.A., Wessler, S., Luderity, O., Sarmiento, M.E., Picogram sensitive assay for endotoxin: Gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharide and lipid A from Gram negative bacteria (1972) Biochim. Biophys. Acta, 261, pp. 284-289
Bettahi, I., Nesburn, A.B., Yoon, S., Zhang, X., Mohebbi, A., Sue, V., Vanderberg, A., BenMohamed, L., Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines (2007) Investigative Ophthalmology and Visual Science, 48 (10), pp. 4643-4653. , DOI 10.1167/iovs.07-0356
Nesburn, A.B., Ramos, T.V., Zhu, X., Asgarzadeh, H., Nguyen, V., Benmohamed, L., Local and systemic B cell and Th1 responses induced following ocular mucosal delivery of multiple epitopes of herpes simplex virus type 1 glycoprotein D together with cytosine-phosphate-guanine adjuvant (2005) Vaccine, 23 (7), pp. 873-883. , DOI 10.1016/j.vaccine.2004.08.019, PII S0264410X04006188
Gibbons, W.A., Hughes, R.A., Charalambous, M., Christodoulou, M., Szeto, A., Aulabough, A.E., Mascagni, P., Toth, I., Lipidic Peptides I. Synthesis resolution and structural elucidation of fatty amino acids and their homo- and hetero-oligomers (1990) Liebigs Ann. Chem., pp. 1175-1183
Krishna, M., Narang, H., The complexity of mitogen-activated protein kinases (MAPKs) made simple (2008) Cell. Mol. Life Sci., 65, pp. 3525-3544
Garcia, J., Lemercier, B., Roman-Roman, S., Rawadi, G., A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF-κB activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways (1998) Journal of Biological Chemistry, 273 (51), pp. 34391-34398. , DOI 10.1074/jbc.273.51.34391
Paludan, S.R., Melchjorsen, J., Malmgaard, L., Mogensen, S.C., Expression of genes for cytokines and cytokine-related functions in leukocytes infected with Herpes simplex virus: Comparison between resistant and suscept3ible mouse strains (2002) European Cytokine Network, 13 (3), pp. 306-316
Kelly, J., Beddall, M.H., Yu, D., Iyer, S.R., Marsh, J.W., Wu, Y., Human macrophages support persistent transcription from unintegrated HIV-1 DNA (2008) Virology, 372 (2), pp. 300-312. , DOI 10.1016/j.virol.2007.11.007, PII S0042682207007623
Wang, W., Ye, L., Ye, L., Li, B., Gao, B., Zeng, Y., Kong, L., She, Y., Up-regulation of IL-6 and TNF-α induced by SARS-coronavirus spike protein in murine macrophages via NF-κB pathway (2007) Virus Research, 128 (1-2), pp. 1-8. , DOI 10.1016/j.virusres.2007.02.007, PII S0168170207000470
Berzofsky, J. A., Ahlers, J. D., Belyakov, I. M., Strategies for designing and optimizing new generation vaccines (2002) Nat. Rev. Immunol., 3, pp. 209-219
Elliott, S. L., Pye, S., Le, T., Mateo, L., Cox, J., MacDonald, L., Scalzo, A. A., Suhrbier, A., Peptide based cytotoxic T-cell vaccines
Gupta, R. K., Siber, G. R., Adjuvants for human vaccines-current status, problems and future prospects (1995) Vaccine, 13, pp. 1263-1276
Moyle, P. M., Toth, I., Self-adjuvanting lipopeptide vaccines (2008) Curr. Med. Chem., 15, p. 506
Olive, C., Ho, M. -F., Dyer, J., Lincoln, D., Barozzi, N., Toth, I., Good, M. F., Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus (2006) Journal of Infectious Diseases, 193 (12), pp. 1666-1676. , DOI 10. 1086/504266
Hayman, W. A., Toth, I., Flinn, N., Scanlon, M., Good, M. F., Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to A helical group a streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology (2002) Immunology and Cell Biology, 80 (2), pp. 178-187. , DOI 10. 1046/j. 1440-1711. 2002. 01067. x
Tam, J. P., Lu, Y. -A., Vaccine engineering: Enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes (1989) Proceedings of the National Academy of Sciences of the United States of America, 86 (23), pp. 9084-9088. , DOI 10. 1073/pnas. 86. 23. 9084
Fitzmaurice, C. J., Brown, L. E., McInerney, T. L., Jackson, D. C., The assembly and immunological properties of non-linear synthetic immunogens containing T-cell and B-cell determinants (1996) Vaccine, 14 (6), pp. 553-560. , DOI 10. 1016/0264-410X (95) 00217-O
Kwok, W. W., Gebe, J. A., Liu, A., Agar, S., Ptacek, N., Hammer, J., Koelle, D. M., Nepom, G. T., Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research (2001) Trends Immunol., 22, pp. 583-588
Bernstein, D. I., Stanberry, L. R., Herpes simplex virus vaccines (1999) Vaccine, 17 (13-14), pp. 1681-1689. , DOI 10. 1016/S0264-410X (98) 00434-4, PII S0264410X98004344
Whitley, R. J., Kimberlin, D. W., Roizman, B., Herpes simplex viruses (1998) Clin. Infect. Dis., 26, pp. 541-553
Cush, S. S., Anderson, K. M., Ravneberg, D. H., Weslow-Schmidt, J. L., Flano, E., Memory generation and maintenance of CD8+ T cell function during viral persistence (2007) Journal of Immunology, 179 (1), pp. 141-153
Chentoufi, A. A., Zhang, X., Lamberth, K., Dasgupta, G., Bettahi, I., Nguyen, A., Wu, M., Benmohamed, L., HLA-A *0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D (2008) J. Immunol., 180, pp. 426-437
Chou, P. Y., Fasman, G. D., Prediction of protein conformation (1974) Biochemistry, 13, pp. 222-245
Taylor, M. F., Paulauskis, J. D., Weller, D. D., Kobzik, L., In vitro efficacy of morpholino-modified antisense oligomers directed against tumor necrosis factor- mRNA (1996) Journal of Biological Chemistry, 271 (29), pp. 17445-17452. , DOI 10. 1074/jbc. 271. 29. 17445
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., Saltiel, A. R., PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo (1995) J. Biol. Chem., 270, pp. 27489-27494
Yin, E. T., Galanos, C., Kinsky, S., Bradshaw, R. A., Wessler, S., Luderity, O., Sarmiento, M. E., Picogram sensitive assay for endotoxin: Gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharide and lipid A from Gram negative bacteria (1972) Biochim. Biophys. Acta, 261, pp. 284-289
Nesburn, A. B., Ramos, T. V., Zhu, X., Asgarzadeh, H., Nguyen, V., Benmohamed, L., Local and systemic B cell and Th1 responses induced following ocular mucosal delivery of multiple epitopes of herpes simplex virus type 1 glycoprotein D together with cytosine-phosphate-guanine adjuvant (2005) Vaccine, 23 (7), pp. 873-883. , DOI 10. 1016/j. vaccine. 2004. 08. 019, PII S0264410X04006188
Gibbons, W. A., Hughes, R. A., Charalambous, M., Christodoulou, M., Szeto, A., Aulabough, A. E., Mascagni, P., Toth, I., Lipidic Peptides I. Synthesis resolution and structural elucidation of fatty amino acids and their homo- and hetero-oligomers (1990) Liebigs Ann. Chem., pp. 1175-1183
Paludan, S. R., Melchjorsen, J., Malmgaard, L., Mogensen, S. C., Expression of genes for cytokines and cytokine-related functions in leukocytes infected with Herpes simplex virus: Comparison between resistant and suscept3ible mouse strains (2002) European Cytokine Network, 13 (3), pp. 306-316
Activation of monocytic cells by immunostimulatory lipids conjugated to peptide antigens
Bacterial derived lipoproteins constitute potent macrophage activators in vivo and are effective stimuli, enhancing the immune response especially with respect to low or non-immunogenic compounds. In the present study we have prepared branched lipopeptide constructs in which different (B- and T-cell) epitopes of Herpes simplex virus type 1, derived from glycoproteins B (gB) and D (gD), are linked to a synthetic lipid core. The ability of the lipid core peptide (LCP) constructs (LCP-gB and LCP-gD) to induce cytokine expression and activate the mitogen-activated protein kinase cascade has been evaluated and compared with the behaviour of the isolated epitopes and the lipid core. In this respect, the use of LCP technology coupled with the use of three different gB or gD peptide epitopes in the same branched constructs could represent an interesting approach in order to obtain efficient delivery systems in the development of a synthetic multiepitopic vaccine for the prevention of viral infections.
Activation of monocytic cells by immunostimulatory lipids conjugated to peptide antigens
No results.
Activation of monocytic cells by immunostimulatory lipids conjugated to peptide antigens